黄连解毒贴通过抑制HMGB1介导的巨噬细胞炎症互作改善X射线放射性皮炎
该研究以1例食管癌放疗患者(总剂量7000cGY,黄连解毒贴治疗14天)为临床展示,并建立X线照射(800cGY连续5天)小鼠放射性皮炎模型及JB6细胞与巨噬细胞共培养体系。结果显示黄连解毒贴可减轻X线所致皮肤损伤、抑制炎症,下调IL-1β、IL-6、TNF-α及Integrin β1、CXCL9、Cytokeratin17,并显著降低HMGB1蛋白水平,其机制为抑制HMGB1介导的上皮细胞与巨噬细胞炎症互作。
要点
- 黄连解毒贴可显著缓解X线诱导的皮肤损伤与炎症反应。
- 其作用与下调HMGB1及IL-1β、IL-6、TNF-α等炎症因子有关。
- HMGB1可能是黄连解毒贴治疗放射性皮炎的有效靶点。
核心结论
- 黄连解毒贴通过抑制HMGB1介导的巨噬细胞与JB6细胞炎症互作治疗放射性皮炎。
- HMGB1可能是黄连解毒贴抑制炎症、改善放射性皮炎皮肤损伤的有效靶点。
研究设计与样本
- 临床展示1例食管癌患者,接受总辐射剂量7000cGY并予黄连解毒贴治疗14天。
- 小鼠右后肢连续X线照射800cGY共5天建立放射性皮炎模型,治疗组自造模起贴敷黄连解毒贴15天。
- 以X线100cGY照射JB6细胞诱导炎症细胞模型,并建立JB6细胞与巨噬细胞共培养体系。
主要发现
- 黄连解毒贴可显著减轻X线诱导的皮肤损伤,抑制皮肤炎症。
- 黄连解毒贴降低炎症细胞因子IL-1β、IL-6、TNF-α及表皮损伤相关因子Integrin β1、CXCL9、Cytokeratin17。
- 黄连解毒贴在体内外显著下调HMGB1蛋白水平。
- X线诱导的JB6细胞释放HMGB1可促进巨噬细胞炎症反应,并反馈加重上皮细胞损伤。
- 黄连解毒贴通过抑制HMGB1介导的上皮细胞与巨噬细胞炎症互作改善放射性皮肤病变。
临床怎么用
- 对于肿瘤放疗相关放射性皮炎,可考虑在规范治疗基础上联合黄连解毒贴外用。
- 黄连解毒贴的作用机制可能涉及抑制HMGB1-TLR4-NF-κB信号通路及下游炎症因子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Huanglian Jiedu plaster (HJP) is a kind of Chinese patent medicine that contains four medicinal plants. It has been clinically proven to be beneficial for the treatment of tumor-associated radiation dermatitis. However, the underlying mechanism of HJP on radiation dermatitis remains unclear. AIM OF THE STUDY: This study aims to investigate the therapeutic effect of HJP on X-ray-induced radiation dermatitis, and how HJP improves the inflammatory response and skin damage of radiation dermatitis. MATERIALS AND METHODS: In this study, We selected a case of esophageal cancer as a clinical demonstration of the efficacy of radiation dermatitis. The patient received a total radiation dose of 7000cGY, and treatment by HJP for 14 days.RD mouse models were established through continuous irradiation with X-ray (800cGY) on the right hind limb of mice for 5 days, and the treatment group mice was applied HJP to the irradiated skin for 15 days from modeling. An inflammatory cellular model was induced through irradiation with X-ray (100cGY) in JB6 cells and a co-culture system of JB6 cell and macrophage was established to examine the effect and mechanism of HJP on the inflammatory interaction of these two cells. The activation of HMGB1-TLR4-NF-κB signaling pathway, and the levels of epidermal injury related factors and inflammatory cytokins were subsequently detected. RESULTS: The results showed that HJP can significantly alleviate X-ray-induced skin injury, inhibiting skin inflammation and reducing the expression of inflammatory cytokins (IL-1β, IL-6, TNF-α) and epidermal damage related factors (Integrin β1, CXCL9 and Cytokeratin17), as well as significantly down-regulated the protein level of HMGB1 (a key DAMPs factor) in vivo and in vitro. Cell co-culture experiments demonstrated that HMGB1 released from X-ray-induced JB6 cells can promote inflammatory response of macrophage, which then feedback aggravate epithelial cell damage, notably, HJP can significantly improve radiation skin lesion by inhibiting HMGB1-mediated inflammatory interaction between epithelial cells and macrophages. CONCLUSION: In summary, these findings indicated the role of HJP in the treatment of RD by inhibiting the inflammatory interaction between macrophage and JB6 cells mediated by HMGB1, which may provide a reliable therapeutic method for RD. Furthermore, HMGB1 may be an effective target for HJP to inhibit inflammation and ameliorate skin damage in RD.
引用
- Wang J, Xie KH, Ren W, et al. Huanglian Jiedu plaster ameliorated X-ray-induced radiation dermatitis injury by inhibiting HMGB1-mediated macrophage-inflammatory interaction. J Ethnopharmacol. 2022. PMID: 36414215. doi:10.1016/j.jep.2022.115917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。